|
1
|
Yicong Y, Wang Y, Denglong W and Baoying
H: Increased CDC6 expression associated with poor prognosis in
patients with clear cell renal cell carcinoma. Front Oncol.
11:6664182021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jing J, Zhao X, Wang J and Li T: Potential
diagnostic and prognostic value and regulatory relationship of long
noncoding RNA CCAT1 and miR-130a-3p in clear cell renal cell
carcinoma. Cancer Cell Int. 21:682021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cao C, Ma Q, Huang X, Li A, Liu J, Ye J
and Gui Y: Targeted demethylation of the PLOD2 mRNA inhibits the
proliferation and migration of renal cell carcinoma. Front Mol
Biosci. 8:6756832021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu G, Wang Q, Xu Y, Li J, Zhang H, Qi G
and Xia Q: Targeting the transcription factor receptor LXR to treat
clear cell renal cell carcinoma: Agonist or inverse agonist? Cell
Death Dis. 10:4162019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cui C, Yang J, Li X, Liu D, Fu L and Wang
X: Functions and mechanisms of circular RNAs in cancer radiotherapy
and chemotherapy resistance. Mol Cancer. 19:582020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yao B, Zhang Q, Yang Z, An F, Nie H, Wang
H, Yang C, Sun J, Chen K, Zhou J, et al: CircEZH2/miR-133b/IGF2BP2
aggravates colorectal cancer progression via enhancing the
stability of m6A-modified CREB1 mRNA. Mol Cancer.
21:1402022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z, Yang T and Xiao J: Circular RNAs:
Promising biomarkers for human diseases. EBioMedicine. 34:267–274.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei W, Ji L, Duan W and Zhu J: Circular
RNA circ_0081001 knockdown enhances methotrexate sensitivity in
osteosarcoma cells by regulating miR-494-3p/TGM2 axis. J Orthop
Surg Res. 16:502021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Chou X, Zhuang M, Zhu C, Hu Y,
Cheng D and Liu Z: circKMT2D contributes to H2O2-attenuated
osteosarcoma progression via the miR-210/autophagy pathway. Exp
Ther Med. 20:652020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Beilerli A, Gareev I, Beylerli O, Yang G,
Pavlov V, Aliev G and Ahmad A: Circular RNAs as biomarkers and
therapeutic targets in cancer. Semin Cancer Biol. 83:242–252. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Y, Xie Z, Chen J, Chen J, Ni W, Ma Y,
Huang K, Wang G, Wang J, Ma J, et al: Circular RNA circTADA2A
promotes osteosarcoma progression and metastasis by sponging
miR-203a-3p and regulating CREB3 expression. Mol Cancer. 18:732019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rong X, Han Q, Lin X, Kremerskothen J and
Wang E: FRMPD1 activates the Hippo pathway via interaction with
WWC3 to suppress the proliferation and invasiveness of lung cancer
cells. Cancer Manag Res. 11:3395–3410. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han Q, Rong X, Wang E and Liu S: WW and
C2 domain-containing protein-3 promoted EBSS-induced
apoptosis through inhibiting autophagy in non-small cell lung
cancer cells. J Thorac Dis. 12:4205–4215. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Zhang J, Zheng T, Mou X and Xin W:
Circ_WWC3 overexpression decelerates the progression of
osteosarcoma by regulating miR-421/PDE7B axis. Open Life Sci.
16:229–241. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C and Li X: Antitumor Activity of
lncRNA NBAT-1 via Inhibition of miR-4504 to Target to WWC3 in
oxaliplatin-resistant colorectal carcinoma. J Healthc Eng.
2022:91215542022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Jiang M, Yao Y and Cai Z: WWC3
inhibits glioma cell proliferation through suppressing the
Wnt/β-catenin signaling pathway. DNA Cell Biol. 37:31–37. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng L, Liu S, Liu F and Sang M, Ju Y, Fan
X, Gu L, Li Z, Geng C and Sang M: ZEB1-mediated transcriptional
upregulation of circWWC3 promotes breast cancer progression through
activating Ras signaling pathway. Mol Ther Nucleic Acids.
22:124–137. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou F, Wang D, Wei W, Chen H, Shi H, Zhou
N, Wu L and Peng R: Comprehensive profiling of circular RNA
expressions reveals potential diagnostic and prognostic biomarkers
in multiple myeloma. BMC Cancer. 20:402020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Zhang Y, Wang P, Fu X and Lin W:
Circular RNAs in renal cell carcinoma: implications for
tumorigenesis, diagnosis, and therapy. Mol Cancer. 19:1492020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang L, Zou X, Zou J and Zhang G:
Functions of circular RNAs in bladder, prostate and renal cell
cancer (Review). Mol Med Rep. 23:3072021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma C, Qin J, Zhang J, Wang X, Wu D and Li
X: Construction and analysis of circular RNA molecular regulatory
networks in clear cell renal cell carcinoma. Mol Med Rep.
21:141–150. 2020.PubMed/NCBI
|
|
22
|
Feng W, Guo R, Zhang D and Zhang R:
Circ-ABCB10 knockdown inhibits the malignant progression of
cervical cancer through microRNA-128-3p/ZEB1 axis. Biol Proced
Online. 23:172021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Erdoğan F, Demirel A and Polat O:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Int J Clin Pract. 58:333–336. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Delahunt B, Eble JN, Egevad L and
Samaratunga H: Grading of renal cell carcinoma. Histopathology.
74:4–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu S, Deng X and Zhang J: Identification
of dysregulated serum miR-508-3p and miR-885-5p as potential
diagnostic biomarkers of clear cell renal carcinoma. Mol Med Rep.
20:5075–5083. 2019.PubMed/NCBI
|
|
26
|
El-Deiry WS, Taylor B and Neal JW: Tumor
evolution, heterogeneity, and therapy for our patients with
advanced cancer: How far have we come? Am Soc Clin Oncol Educ Book.
37:e8–e15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gui CP, Liao B, Luo CG, Chen YH, Tan L,
Tang YM, Li JY, Hou Y, Song HD, Lin HS, et al: circCHST15 is a
novel prognostic biomarker that promotes clear cell renal cell
carcinoma cell proliferation and metastasis through the
miR-125a-5p/EIF4EBP1 axis. Mol Cancer. 20:1692021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang MX, Wang JL, Mo CQ, Mao XP, Feng ZH,
Li JY, Lin HS, Song HD, Xu QH, Wang YH, et al: CircME1 promotes
aerobic glycolysis and sunitinib resistance of clear cell renal
cell carcinoma through cis-regulation of ME1. Oncogene.
41:3979–3990. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zhang Y, Su X, Qiu Q, Yuan Y, Weng
C, Zou S, Tian Y, Han W, Liu P, et al: Circular RNA circDVL1
inhibits clear cell renal cell carcinoma progression through the
miR-412-3p/PCDH7 axis. Int J Biol Sci. 18:1491–1507. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Downs TM, Schultzel M, Shi H, Sanders C,
Tahir Z and Sadler GR: Renal cell carcinoma: Risk assessment and
prognostic factors for newly diagnosed patients. Crit Rev Oncol
Hematol. 70:59–70. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miller K, Bergmann L, Doehn C, Grünwald V,
Gschwend JE, Ivanyi P and Kuczyk MA: Interdisciplinary
recommendations for the treatment of advanced renal cell carcinoma.
Aktuel Urol. 53:403–415. 2022.(In German). PubMed/NCBI
|
|
32
|
Babin L, Andraos E, Fuchs S, Pyronnet S,
Brunet E and Meggetto F: From circRNAs to fusion circRNAs in
hematological malignancies. JCI Insight. 6:e1515132021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang G, Liang M, Liu H, Huang J, Li P,
Wang C, Zhang Y, Lin Y and Jiang X: CircRNA hsa_circRNA_104348
promotes hepatocellular carcinoma progression through modulating
miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway. Cell
Death Dis. 11:10652020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng X, Huang M, Xing L, Yang R, Wang X,
Jiang R, Zhang L and Chen J: The circRNA circSEPT9 mediated by E2F1
and EIF4A3 facilitates the carcinogenesis and development of
triple-negative breast cancer. Mol Cancer. 19:732020. View Article : Google Scholar : PubMed/NCBI
|
